A Retrospective Study of Ultrasound Characteristics and Macroscopic Findings in Confirmed Malignant Pleural Effusion

被引:4
|
作者
Zivkovic, Nevenka Piskac [1 ]
Cikara, Igor [1 ,2 ]
Novak, Nina Petra [1 ]
Brkljacic, Boris [1 ,3 ]
Tudoric, Neven [1 ,3 ]
机构
[1] Univ Hosp Dubrava, Zagreb, Croatia
[2] Univ Josip Juraj Strossmayer Osijek, Fac Med Osijek, Osijek, Croatia
[3] Univ Zagreb, Sch Med, Zagreb, Croatia
关键词
ENDOTHELIAL GROWTH-FACTOR; PROINFLAMMATORY CYTOKINES; SONOGRAPHY; MANAGEMENT; DIAGNOSIS; FLUID;
D O I
10.1155/2019/5628267
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background. A definitive diagnosis of malignant pleural effusion (MPE) is reached by cytological or histological assessment, but thorough analysis of the ultrasound features of the effusion as well as pleural thickening or nodularity can also be of significant diagnostic help. Objective. To assess the relationship of specific ultrasound characterisctics and macroscopic features of confirmed malignant pleural effusion, thus increasing the diagnostic potential of thoracic ultrasound. Methods. The findings of thoracic ultrasonography performed prior to initial thoracentesis in 104 patients with subsequently confirmed malignant pleural effusion were analyzed with regard to the macroscopic features of the pleural effusion. Results. Distribution in terms of frequency of hemorrhagic/sanguinolent (n=64) in relation to nonhemorrhagic transparent/opaque (n=40) MPE, regardless of their ultrasound characteristics, did not yield a statistically significant correlation (p=0.159). Conversely, the frequency distribution of hemorrhagic pleural effusions (n=8) in relation to nonhemorrhagic effusions (n=1), in the group of septated MPE, showed a statistically significant difference (p<0.001). The least number of patients (0.96%) had a complex septated MPE combined with the macroscopic appearance of a serous/transparent nonhemorrhagic effusion, which suggests that this combination is a sporadic occurrence and may have a diagnostic significance for this patient group. Conclusion. The incidence of specific combinations of the ultrasound characteristics and macroscopic appearance of MPEs showed different frequency distributions, which may improve the diagnostic value of thoracic ultrasound in this patient population.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Prevalence, risk factors, and in-hospital outcome of pleural effusion in liver cirrhosis: a retrospective observational study
    Hou, Feifei
    Qi, Xingshun
    Ning, Zheng
    Zhao, Jiancheng
    Zhang, Xintong
    Deng, Han
    Peng, Ying
    Li, Jing
    Yao, Hui
    Li, Hongyu
    Guo, Xiaozhong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 3265 - U7567
  • [32] Pleural fluid carbohydrate antigen 72-4 and malignant pleural effusion: a diagnostic test accuracy study
    Cao, Xi-Shan
    Yan, Li
    Jiang, Ting-Wang
    Huang, Jin-Hong
    Chen, Hong
    Porcel, Jose M.
    Zheng, Wen-Qi
    Hu, Zhi-De
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2024, 18
  • [33] Predicting malignant pleural effusion during diagnostic pleuroscopy with biopsy: A prospective multicentre study
    Grosu, Horiana B.
    Kern, Ryan
    Maldonado, Fabien
    Casal, Roberto
    Andersen, Clark R.
    Li, Liang
    Eapen, Georgie
    Ost, David
    Jimenez, Carlos
    Frangopoulos, Frangiskos
    Sabath, Bruce
    Vakil, Erik
    Schwalk, Audra
    Marcoux, Mathieu
    Sagar, Ala Eddin
    Nasim, Faria
    Lin, Julie
    Salahudin, Moiz
    Arain, Hasan Muhammad
    Noor, Laila
    Montanez, Diana
    Stewart, John
    Mullon, John
    Michael, Michalis
    Porfyridis, Ilias
    RESPIROLOGY, 2022, 27 (05) : 350 - 356
  • [34] Comparison of cytology, chest computed and positron emission tomography findings in malignant pleural effusion from lung cancer
    Brun, Clement
    Gay, Pierre
    Cottier, Michele
    Karpathiou, Georgia
    Patoir, Arnaud
    Tiffet, Oliviet
    Barral, Fabrice-Guy
    Vergnon, Jean-Michel
    Froudarakis, Marios E.
    JOURNAL OF THORACIC DISEASE, 2018, 10 (12) : 6903 - 6911
  • [35] Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: a phase II study with pharmacokinetic analysis
    Lombardi, Giuseppe
    Nicoletto, Maria Ornella
    Gusella, Milena
    Fiduccia, Pasquale
    Dalla Palma, Maurizia
    Zuin, Andrea
    Fiore, Davide
    Donach, Martin
    Zagonel, Vittorina
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (03) : 781 - 787
  • [36] Diagnostic value of survivin for malignant pleural effusion: a clinical study and meta-analysis
    Tian, Panwen
    Shen, Yongchun
    Wan, Chun
    Yang, Ting
    An, Jing
    Yi, Qun
    Chen, Lei
    Wang, Tao
    Wang, Ye
    Wen, Fuqiang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (09): : 5880 - 5887
  • [37] Outcome and clinical characteristics in pleural empyema: A retrospective study
    Nielsen, Jannie
    Meyer, Christian N.
    Rosenlund, Signe
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2011, 43 (6-7) : 430 - 435
  • [38] Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (±talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusion
    Fitzgerald, Deirdre B.
    Sidhu, Calvin
    Budgeon, Charley
    Tan, Ai Ling
    Read, Catherine A.
    Kwan, Benjamin C. H.
    Smith, Nicola Ann
    Fysh, Edward T.
    Muruganandan, Sanjeevan
    Saghaie, Tajalli
    Shrestha, Ranjan
    Badiei, Arash
    Nguyen, Phan
    Burke, Andrew
    Goddard, John
    Windsor, Morgan
    McDonald, Julie
    Wright, Gavin
    Czarnecka, Kasia
    Sivakumar, Parthipan
    Yasufuku, Kazuhiro
    Feller-Kopman, David J.
    Maskell, Nick A.
    Murray, Kevin
    Lee, Y. C. Gary
    TRIALS, 2022, 23 (01)
  • [39] Clinical characteristics and prognostic factors of non-malignant pleural effusions in hospitalised patients: a retrospective cohort study
    Wang, Danni
    Niu, Yue
    Ma, Yangyang
    Tang, Li
    Zhang, Qingtao
    Zhang, Li
    Sun, Xuefeng
    Mei, Yan
    Cai, Guangyan
    Chen, Xiangmei
    Li, Ping
    BMJ OPEN, 2024, 14 (07):
  • [40] A phase II study of cediranib as palliative treatment in patients with symptomatic malignant ascites or pleural effusion
    Mulder, S. F.
    Boers-Sonderen, M. J.
    van der Heijden, H. F. M.
    Vissers, K. C. P.
    Punt, C. J. A.
    van Herpen, C. M. L.
    TARGETED ONCOLOGY, 2014, 9 (04) : 331 - 338